China Phosphodiesterase Inhibitor Market Research Report Forecast 2017 to 2022

December 2017 | 132 pages | ID: C9BC2CE0811EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The China Phosphodiesterase Inhibitor Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Phosphodiesterase Inhibitor industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Phosphodiesterase Inhibitor market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals

China Phosphodiesterase Inhibitor Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Phosphodiesterase Inhibitor Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PHOSPHODIESTERASE INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of Phosphodiesterase Inhibitor
1.2 Phosphodiesterase Inhibitor Market Segmentation by Type
  1.2.1 China Production Market Share of Phosphodiesterase Inhibitor by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Phosphodiesterase Inhibitor Market Segmentation by Application
  1.3.1 Phosphodiesterase Inhibitor Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Phosphodiesterase Inhibitor (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON PHOSPHODIESTERASE INHIBITOR INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Phosphodiesterase Inhibitor Industry

CHAPTER 3 CHINA PHOSPHODIESTERASE INHIBITOR MARKET COMPETITION BY MANUFACTURERS

3.1 China Phosphodiesterase Inhibitor Production and Share by Manufacturers (2015 and 2016)
3.2 China Phosphodiesterase Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Phosphodiesterase Inhibitor Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Phosphodiesterase Inhibitor Manufacturing Base Distribution, Production Area and Product Type
3.5 Phosphodiesterase Inhibitor Market Competitive Situation and Trends
  3.5.1 Phosphodiesterase Inhibitor Market Concentration Rate
  3.5.2 Phosphodiesterase Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA PHOSPHODIESTERASE INHIBITOR CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Phosphodiesterase Inhibitor Capacity, Production and Growth (2012-2017)
4.2 China Phosphodiesterase Inhibitor Revenue and Growth (2012-2017)
4.3 China Phosphodiesterase Inhibitor Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA PHOSPHODIESTERASE INHIBITOR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Phosphodiesterase Inhibitor Production and Market Share by Type (2012-2017)
5.2 China Phosphodiesterase Inhibitor Revenue and Market Share by Type (2012-2017)
5.3 China Phosphodiesterase Inhibitor Price by Type (2012-2017)
5.4 China Phosphodiesterase Inhibitor Production Growth by Type (2012-2017)

CHAPTER 6 CHINA PHOSPHODIESTERASE INHIBITOR MARKET ANALYSIS BY APPLICATION

6.1 China Phosphodiesterase Inhibitor Consumption and Market Share by Application (2012-2017)
6.2 China Phosphodiesterase Inhibitor Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA PHOSPHODIESTERASE INHIBITOR MANUFACTURERS ANALYSIS

7.1 Actelion Pharmaceuticals
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 United Therapeutics Corporation
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Gilead sciences
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Bayer AG
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 SteadyMed
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 GlaxoSmithKline
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Pfizer
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Reata Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Arena Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 PHOSPHODIESTERASE INHIBITOR MANUFACTURING COST ANALYSIS

8.1 Phosphodiesterase Inhibitor Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Phosphodiesterase Inhibitor

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Phosphodiesterase Inhibitor Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA PHOSPHODIESTERASE INHIBITOR MARKET FORECAST (2017-2022)

12.1 China Phosphodiesterase Inhibitor Production, Revenue Forecast (2017-2022)
12.2 China Phosphodiesterase Inhibitor Production, Consumption Forecast by Regions (2017-2022)
12.3 China Phosphodiesterase Inhibitor Production Forecast by Type (2017-2022)
12.4 China Phosphodiesterase Inhibitor Consumption Forecast by Application (2017-2022)
12.5 Phosphodiesterase Inhibitor Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Phosphodiesterase Inhibitor
Figure China Production Market Share of Phosphodiesterase Inhibitor by Type in 2016
Table Phosphodiesterase Inhibitor Consumption Market Share by Application in 2016
Figure China Phosphodiesterase Inhibitor Revenue (Million USD) and Growth Rate (2012-2021)
Table China Phosphodiesterase Inhibitor Capacity of Key Manufacturers (2015 and 2016)
Table China Phosphodiesterase Inhibitor Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Phosphodiesterase Inhibitor Capacity of Key Manufacturers in 2015
Figure China Phosphodiesterase Inhibitor Capacity of Key Manufacturers in 2016
Table China Phosphodiesterase Inhibitor Production of Key Manufacturers (2015 and 2016)
Table China Phosphodiesterase Inhibitor Production Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase Inhibitor Production Share by Manufacturers
Figure 2016 Phosphodiesterase Inhibitor Production Share by Manufacturers
Table China Phosphodiesterase Inhibitor Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Phosphodiesterase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table 2016 China Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table China Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers in 2016
Table Manufacturers Phosphodiesterase Inhibitor Manufacturing Base Distribution and Sales Area
Table Manufacturers Phosphodiesterase Inhibitor Product Type
Figure Phosphodiesterase Inhibitor Market Share of Top 3 Manufacturers
Figure Phosphodiesterase Inhibitor Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Phosphodiesterase Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actelion Pharmaceuticals Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Actelion Pharmaceuticals Phosphodiesterase Inhibitor Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Gilead sciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Gilead sciences Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Gilead sciences Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Phosphodiesterase Inhibitor Market Share (2012-2017)
Table SteadyMed Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SteadyMed Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table SteadyMed Phosphodiesterase Inhibitor Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Reata Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Arena Pharmaceuticals Phosphodiesterase Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Phosphodiesterase Inhibitor Market Share (2012-2017)
Figure Production Revenue Share of Phosphodiesterase Inhibitor by Type (2012-2017)
Figure 2015 Revenue Market Share of Phosphodiesterase Inhibitor by Type
Table China Phosphodiesterase Inhibitor Price by Type (2012-2017)
Figure China Phosphodiesterase Inhibitor Production Growth by Type (2012-2017)
Table China Phosphodiesterase Inhibitor Consumption by Application (2012-2017)
Table China Phosphodiesterase Inhibitor Consumption Market Share by Application (2012-2017)
Figure China Phosphodiesterase Inhibitor Consumption Market Share by Application in 2016
Table China Phosphodiesterase Inhibitor Consumption Growth Rate by Application (2012-2017)
Figure China Phosphodiesterase Inhibitor Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase Inhibitor
Figure Manufacturing Process Analysis of Phosphodiesterase Inhibitor
Figure Phosphodiesterase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015
Table Major Buyers of Phosphodiesterase Inhibitor
Table Distributors/Traders List
Figure China Phosphodiesterase Inhibitor Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Table China Phosphodiesterase Inhibitor Production, Import, Export and Consumption Forecast (2017-2022)
Table China Phosphodiesterase Inhibitor Production Forecast by Type (2017-2022)
Table China Phosphodiesterase Inhibitor Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals
Merck